FDA NDC Directory · JSON-LD · Markdown

Kimyrsa

NDC 70842-225 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameoritavancin diphosphate
Labeler / ManufacturerMelinta Therapeutics, LLC
Marketing categoryNew Drug Application (innovator) · App NDA214155
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsORITAVANCIN DIPHOSPHATE (1200 mg/40mL)
Marketing started20210323
Package count1

External sources

Source: openFDA. Public-domain (CC0).